Series A startup

Who invested in AnHorn Medicines

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Funding summaryUpdated 26 Oct 2026

$10Mraised across 1 round since 2023, from 1 source

Latest round
Series A, $10MApr 2023
Investors
1
See who backed them

The rounds

  1. Apr 2023
    Series A$10M

    Source recorded

Founders and team

From AnHorn Medicines's own website: 1 founder, 3 on the team.

Dr. Lin Chu-ChiangFounder and President
  • Dr. Chen Shu-JenChief Scientific Officer
  • Leo RuanChief Financial Officer
  • Wendy LinBusiness Development Director

Everyone who backed them

Taiwania CapitalGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about AnHorn Medicines

Who invested in AnHorn Medicines?

AnHorn Medicines's investors include Taiwania Capital.

How much has AnHorn Medicines raised?

AnHorn Medicines has raised $10M across 1 round since 2023.

When did AnHorn Medicines last raise?

AnHorn Medicines's most recent round was a Series A of $10M in Apr 2023.

What was AnHorn Medicines's biggest round?

Its most recent round, $10M in Apr 2023, is also its largest on record.

Who backed AnHorn Medicines first?

AnHorn Medicines's first round on record, in Apr 2023, was backed by Taiwania Capital.

What stage is AnHorn Medicines at?

AnHorn Medicines's latest named round is a Series A, in Apr 2023.

Companies like AnHorn Medicines

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.